Clinical Trial Update: Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating fexofenadine, desloratadine, and placebo for suppression of wheal and flare in allergic rhinitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Desloratadine (desloratadine)
• Fexofenadine (fexofenadine)

Snippet

Sponsor: Sanofi | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED